Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT06118788 · RECRUITING
Trial details
- NCT number
- NCT06118788
- Sponsor
- Guangzhou Bio-gene Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-07
- Primary completion
- 2027-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.